{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:38:37Z","timestamp":1793986717578,"version":"4.8.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T00:00:00Z","timestamp":1562889600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T00:00:00Z","timestamp":1562889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12890-019-0882-y","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T10:04:14Z","timestamp":1562925854000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Randomized controlled trials of pharmacological treatments to prevent COPD exacerbations: applicability to real-life patients"],"prefix":"10.1186","volume":"19","author":[{"name":"on behalf of Initiatives BPCO scientific committee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5265-2874","authenticated-orcid":false,"given":"Laurie","family":"Pahus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-R\u00e9gis","family":"Burgel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Paillasseur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Chanez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,12]]},"reference":[{"key":"882_CR1","doi-asserted-by":"publisher","unstructured":"Rycroft CE, Heyes A, Lanza L, Becker K. Epidemiology of chronic obstructive pulmonary disease: a literature review. Int J Chron Obstruct Pulmon Dis. 2012. https:\/\/doi.org\/10.2147\/COPD.S32330 PubMed PMID: 22927753; PubMed Central PMCID: PMCPMC3422122.","DOI":"10.2147\/COPD.S32330"},{"key":"882_CR2","doi-asserted-by":"publisher","unstructured":"Blanchette CM, Dalal AA, Mapel D. Changes in COPD demographics and costs over 20 years. J Med Econ. 2012. https:\/\/doi.org\/10.3111\/13696998.2012.713880 PubMed PMID: 22812689 .","DOI":"10.3111\/13696998.2012.713880"},{"key":"882_CR3","doi-asserted-by":"publisher","unstructured":"Chapman KR, Mannino DM, Soriano JB, Vermeire PA, Buist AS, Thun MJ, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2006 doi: https:\/\/doi.org\/10.1183\/09031936.06.00024505 . PubMed PMID: 16387952 .","DOI":"10.1183\/09031936.06.00024505"},{"key":"882_CR4","doi-asserted-by":"crossref","unstructured":"Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998; PubMed PMID: 9603117 .","DOI":"10.1164\/ajrccm.157.5.9709032"},{"key":"882_CR5","doi-asserted-by":"crossref","unstructured":"Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002; PubMed PMID: 12324669; PubMed Central PMCID: PMCPMC1746193.","DOI":"10.1136\/thorax.57.10.847"},{"key":"882_CR6","doi-asserted-by":"publisher","unstructured":"Suissa S, Dell'Aniello S, Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax. 2012. https:\/\/doi.org\/10.1136\/thoraxjnl-2011-201518 PubMed PMID: 22684094; PubMed Central PMCID: PMCPMC3505864.","DOI":"10.1136\/thoraxjnl-2011-201518"},{"key":"882_CR7","doi-asserted-by":"publisher","unstructured":"Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J. 2006. https:\/\/doi.org\/10.1183\/09031936.00133805 PubMed PMID: 17138679.","DOI":"10.1183\/09031936.00133805"},{"key":"882_CR8","doi-asserted-by":"publisher","unstructured":"Hurst JR, Vestbo J, Anzueto A, Locantore N, M\u00fcllerova H, Tal-Singer R, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010. https:\/\/doi.org\/10.1056\/NEJMoa0909883 PubMed PMID: 20843247 .","DOI":"10.1056\/NEJMoa0909883"},{"key":"882_CR9","doi-asserted-by":"publisher","unstructured":"FitzGerald JM. Targeting lung attacks. Thorax. 2011. https:\/\/doi.org\/10.1136\/thx.2010.156760 PubMed PMID: 21398372.","DOI":"10.1136\/thx.2010.156760"},{"key":"882_CR10","unstructured":"From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017. Available from: http:\/\/goldcopd.org ."},{"key":"882_CR11","doi-asserted-by":"publisher","unstructured":"Halpin DM, Kerkhof M, Soriano JB, Mikkelsen H, Price DB. Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy. Respir Res. 2016. https:\/\/doi.org\/10.1186\/s12931-016-0433-5 PubMed PMID: 27663386 ; PubMed Central PMCID: PMCPMC5034631 .","DOI":"10.1186\/s12931-016-0433-5"},{"key":"882_CR12","doi-asserted-by":"publisher","unstructured":"Scichilone N, Basile M, Battaglia S, Bellia V. What proportion of chronic obstructive pulmonary disease outpatients is eligible for inclusion in randomized clinical trials? Respiration. 2014. https:\/\/doi.org\/10.1159\/000355082 PubMed PMID: 24281343 .","DOI":"10.1159\/000355082"},{"key":"882_CR13","doi-asserted-by":"publisher","unstructured":"Travers J, Marsh S, Caldwell B, Williams M, Aldington S, Weatherall M, et al. External validity of randomized controlled trials in COPD. Respir Med. 2007. https:\/\/doi.org\/10.1016\/j.rmed.2006.10.011 PubMed PMID: 17113277 .","DOI":"10.1016\/j.rmed.2006.10.011"},{"key":"882_CR14","doi-asserted-by":"crossref","unstructured":"Herland K, Akselsen JP, Skj\u00f8nsberg OH, Bjermer L. How representative are clinical study patients with asthma or COPD for a larger \u201creal life\u201d population of patients with obstructive lung disease? Respir Med. 2005; PubMed PMID: 15672843 .","DOI":"10.1016\/j.rmed.2004.03.026"},{"key":"882_CR15","doi-asserted-by":"publisher","unstructured":"Kruis AL, St\u00e4llberg B, Jones RC, Tsiligianni IG, Lisspers K, van der Molen T, et al. Primary care COPD patients compared with large pharmaceutically-sponsored COPD studies: an UNLOCK validation study. PLoS One. 2014. https:\/\/doi.org\/10.1371\/journal.pone.0090145 PubMed PMID: 24598945; PubMed Central PMCID: PMCPMC3943905.","DOI":"10.1371\/journal.pone.0090145"},{"key":"882_CR16","doi-asserted-by":"publisher","unstructured":"Walker S, Fingleton J, Weatherall M, Beasley R. Limited generalisability of UPLIFT findings to clinical practice. Thorax. 2013. https:\/\/doi.org\/10.1136\/thoraxjnl-2013-203724 PubMed PMID: 23744029.","DOI":"10.1136\/thoraxjnl-2013-203724"},{"key":"882_CR17","doi-asserted-by":"publisher","unstructured":"Travers J, Marsh S, Williams M, Weatherall M, Caldwell B, Shirtcliffe P, et al. External validity of randomised controlled trials in asthma: to whom do the results of the trials apply? Thorax. 2007. https:\/\/doi.org\/10.1136\/thx.2006.066837 PubMed PMID: 17105779; PubMed Central PMCID: PMCPMC2117157.","DOI":"10.1136\/thx.2006.066837"},{"key":"882_CR18","doi-asserted-by":"publisher","unstructured":"Pahus L, Alagha K, Sofalvi T, Vachier I, Bourdin A, Molinari N, et al. External validity of randomized controlled trials in severe asthma. Am J Respir Crit Care Med. 2015. https:\/\/doi.org\/10.1164\/rccm.201502-0391LE PubMed PMID: 26177176.","DOI":"10.1164\/rccm.201502-0391LE"},{"key":"882_CR19","doi-asserted-by":"publisher","unstructured":"Roche N, Reddel HK, Agusti A, Bateman ED, Krishnan JA, Martin RJ, et al. Integrating real-life studies in the global therapeutic research framework. Lancet Respir Med. 2013. https:\/\/doi.org\/10.1016\/S2213-2600(13)70199-1 PubMed PMID: 24461762.","DOI":"10.1016\/S2213-2600(13)70199-1"},{"key":"882_CR20","doi-asserted-by":"publisher","unstructured":"Burgel PR, Nesme-Meyer P, Chanez P, Caillaud D, Carr\u00e9 P, Perez T, et al. Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest. 2009. https:\/\/doi.org\/10.1378\/chest.08-2062 PubMed PMID: 19017866.","DOI":"10.1378\/chest.08-2062"},{"key":"882_CR21","doi-asserted-by":"publisher","unstructured":"Rothnie KJ, M\u00fcllerov\u00e1 H, Smeeth L, Quint JK. Natural history of chronic obstructive pulmonary disease exacerbations in a general practice-based population with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018. https:\/\/doi.org\/10.1164\/rccm.201710-2029OC PubMed PMID: 29474094; PubMed Central PMCID: PMCPMC6118021.","DOI":"10.1164\/rccm.201710-2029OC"},{"key":"882_CR22","doi-asserted-by":"publisher","unstructured":"Woodruff PG, Barr RG, Bleecker E, Christenson SA, Couper D, Curtis JL, et al. Clinical significance of symptoms in smokers with preserved pulmonary function. N Engl J Med 2016 doi: https:\/\/doi.org\/10.1056\/NEJMoa1505971 . PubMed PMID: 27168432; PubMed Central PMCID: PMCPMC4968204.","DOI":"10.1056\/NEJMoa1505971"},{"key":"882_CR23","doi-asserted-by":"publisher","unstructured":"Tan WC, Sin DD, Bourbeau J, Hernandez P, Chapman KR, Cowie R, et al. Characteristics of COPD in never-smokers and ever-smokers in the general population: results from the CanCOLD study. Thorax. 2015. https:\/\/doi.org\/10.1136\/thoraxjnl-2015-206938 PubMed PMID: 26048404 .","DOI":"10.1136\/thoraxjnl-2015-206938"},{"key":"882_CR24","doi-asserted-by":"publisher","unstructured":"Denguezli M, Daldoul H, Harrabi I, Gnatiuc L, Coton S, Burney P, et al. COPD in nonsmokers: reports from the Tunisian population-based burden of obstructive lung disease study. PLoS One. 2016. https:\/\/doi.org\/10.1371\/journal.pone.0151981 PubMed PMID: 27010214 ; PubMed Central PMCID: PMCPMC4807055 .","DOI":"10.1371\/journal.pone.0151981"},{"key":"882_CR25","doi-asserted-by":"publisher","unstructured":"Lamprecht B, McBurnie MA, Vollmer WM, Gudmundsson G, Welte T, Nizankowska-Mogilnicka E, et al. COPD in never smokers: results from the population-based burden of obstructive lung disease study. Chest. 2011. https:\/\/doi.org\/10.1378\/chest.10-1253 PubMed PMID: 20884729 ; PubMed Central PMCID: PMCPMC3168866.","DOI":"10.1378\/chest.10-1253"},{"key":"882_CR26","doi-asserted-by":"publisher","unstructured":"Silva GE, Sherrill DL, Guerra S, Barbee RA. Asthma as a risk factor for COPD in a longitudinal study. Chest. 2004. https:\/\/doi.org\/10.1378\/chest.126.1.59 PubMed PMID: 15249443.","DOI":"10.1378\/chest.126.1.59"},{"key":"882_CR27","doi-asserted-by":"publisher","unstructured":"Koblizek V, Milenkovic B, Barczyk A, Tkacova R, Somfay A, Zykov K, et al. Phenotypes of COPD patients with a smoking history in central and Eastern Europe: the POPE study. Eur Respir J. 2017. https:\/\/doi.org\/10.1183\/13993003.01446-2016 PubMed PMID: 28495687; PubMed Central PMCID: PMCPMC5460642.","DOI":"10.1183\/13993003.01446-2016"},{"key":"882_CR28","doi-asserted-by":"publisher","unstructured":"Putcha N, Drummond MB, Wise RA, Hansel NN. Comorbidities and chronic obstructive pulmonary disease: prevalence, influence on outcomes, and management. Semin Respir Crit Care Med. 2015. https:\/\/doi.org\/10.1055\/s-0035-1556063 PubMed PMID: 26238643 ; PubMed Central PMCID: PMCPMC5004772 .","DOI":"10.1055\/s-0035-1556063"},{"key":"882_CR29","doi-asserted-by":"publisher","unstructured":"Smith MC, Wrobel JP. Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2014. https:\/\/doi.org\/10.2147\/COPD.S49621 PubMed PMID: 25210449 ; PubMed Central PMCID: PMCPMC4154888 .","DOI":"10.2147\/COPD.S49621"},{"key":"882_CR30","doi-asserted-by":"publisher","unstructured":"Westerik JA, Metting EI, van Boven JF, Tiersma W, Kocks JW, Schermer TR. Associations between chronic comorbidity and exacerbation risk in primary care patients with COPD. Respir Res. 2017. https:\/\/doi.org\/10.1186\/s12931-017-0512-2 PubMed PMID: 28166777 ; PubMed Central PMCID: PMCPMC5294875 .","DOI":"10.1186\/s12931-017-0512-2"},{"key":"882_CR31","doi-asserted-by":"publisher","unstructured":"Roche N, Reddel H, Martin R, Brusselle G, Papi A, Thomas M, et al. Quality standards for real-world research. Focus on observational database studies of comparative effectiveness. Ann Am Thorac Soc. 2014. https:\/\/doi.org\/10.1513\/AnnalsATS.201309-300RM PubMed PMID: 24559028 .","DOI":"10.1513\/AnnalsATS.201309-300RM"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-019-0882-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12890-019-0882-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-019-0882-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T19:44:13Z","timestamp":1663962253000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-019-0882-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,12]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["882"],"URL":"https:\/\/doi.org\/10.1186\/s12890-019-0882-y","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,12]]},"assertion":[{"value":"25 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"LP has no conflicts of interest to report.PRB reports personal fees from Astra Zeneca, personal fees from Boehringer Ingelheim, personal fees from Chiesi, personal fees from GSK, personal fees from Novartis, personal fees from TEVA, personal fees from Vertex, outside the submitted work.NR reports grants and personal fees from Boehringer Ingelheim, Novartis, Pfizer and personal fees from Teva, GSK, AstraZeneca, Chiesi, Mundipharma, Cipla, Sanofi, Sandoz, 3\u2009M, Zambon outside the submitted work.JLP has no conflicts of interest to report.PC, as an advisory board member, consultant or lecturer, has previously received honoraria or grants from Boehringer Ingeheim, Almirall, Centocor, GSK, MSD, Astra Zeneca, Novartis, Teva, Chiesi, Shering Plough and Amu. None of the latter participated in or had any influence over the present analysis or manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"127"}}